Addition Therapeutics raised $106.5 million to advance its all-RNA PRINT™ platform and expand genomic medicine approaches for both chronic and rare diseases.
Addition Therapeutics raised $106.5 million to advance its all-RNA PRINT™ platform and expand genomic medicine approaches for both chronic and rare diseases.